TJX earnings beat, Revenue misses in Q2
Investing.com - TJX (NYSE:TJX) reported on Wednesday second quarter {{erl-8227||earnings that beat analysts' forecasts and revenue that fell short of expectations. TJX announced earnings...
Strong Buy
or
Cipla News & Analysis
-
-
Stocks Under Focus: Cipla, NTPC, Mahanagar Gas, Navkar Corp & More
By Malvika Gurung Investing.com -- Cipla (NS:CIPL): Ashish Adukia has been appointed as the global CFO and key managerial personnel of the pharmaceutical giant, while Dinesh Jain’s...
-
Stocks in news: HDFC AMC, Ansal Housing, Bajaj Hindusthan, Cipla and more
Stocks in news: HDFC Asset Management Company, Ansal Housing, Bajaj Hindusthan, Cipla, Bajaj Electricals, Future Lifestyle Fashions and more
-
Stocks to Watch: Cipla, NTPC, Adani group, SBI Cards, Hind Zinc, Nxtdigital
Stocks to Watch: ICICI Securities, Axis Capital and Citigroup Global Markets are among the 5 investment bankers selected to manage the sale of the government's 29.53% residual stake in...
-
Stocks to Watch Today: NTPC, Cipla, SAIL, Tata Chemicals, and Others
Stocks to watch today: Shares of firms like NTPC, Cipla, SAIL, Tata Chemicals, and others will be in focus in Friday's trade
-
Stocks in the news: NTPC, Cipla, SAIL, Mahanagar Gas and Future Group stocks
State-owned power giant NTPC floated a tender to raise Rs 5,000 crore term loan from financial institutions. As per the document, the bids can be submitted till 1100 hours on August...
-
Stocks to Watch Today | Cipla, SBI Cards, Bharat Gears, and others in news today
Stocks to Watch: Check out the companies making headlines before the opening bell.
-
Indian Finance Minister Issues Warnings Regarding Crypto
The Indian finance minister suggested against using cryptocurrency.The law enforcement organization blocked the assets of two crypto exchanges.At a BJP Economic Cell event on Saturday,...
-
Buy Cipla, target price Rs 1125: Axis Securities
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 82542.57 Crore) operating in Pharmaceuticals sector.
-
Buy Cipla, target price Rs 1110: Prabhudas Lilladher
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 81586.39 Crore) operating in Pharmaceuticals sector.
-
Brokerages see up to 20% upside in Cipla post Q1 results; time to buy?
Cipla is on track to launch key products, such as gAdvair, gAbraxane, gRevlimid and three peptide products over FY23-24, it said, adding that the US sales run-rate will improve from H2FY23,...
-
Stocks to Watch: Yes Bank, Cipla, Bank of Baroda, Zomato, HDFC, ITC, NTPC
Stocks to Watch today: ITC, UPL, Zomato, Arvind, Bajaj Consumer Care, among others will release their Q1 earnings today.
-
Corporate Actions Lined Up For Jul 29; Cos Releasing Q1 Earnings on Saturday
By Malvika Gurung Investing.com -- A slew of companies is lined up to conduct different corporate actions on Friday, including June quarterly earnings announcements and board meetings, among...
-
Cipla Q1 revenue may be muted on high base, low Covid drug sales: Analysts
Cipla Q1 results preview: Analysts attribute the likely dull performance due to the high base of last year, and the reduction in revenue contribution from Covid-19 therapies in the recent...
-
Cipla's step-down subsidiary in US to divest 25.93% stake held in Avenue Therapeutics
Powered by Capital Market - Live News
-
Upcoming Q1 Results in the Week: Maruti Suzuki, TaMo, HDFC, Axis Bank & More
By Malvika Gurung Investing.com -- The country’s most valued company by market capitalization Reliance Industries (NS:RELI) posted a double-digit bottomline growth, along with the best...
-
-
R&D spends of pharma companies grow slower than topline in the last 5 years
Though value added projects are being undertaken, companies need to step up R&D spends as innovation is the only way to fight pricing pressures
-
Mega & Large-Cap Stocks in Focus: LIC, Bharti Airtel, Syngene, Jindal Steel & More
By Malvika Gurung Investing.com -- Cipla (NS:CIPL): Subsidiary Cipla Health has signed agreements for the acquisition of nutritional supplement brand Endura Mass from Medinnbelle...
-
Cipla forays into nutritional wellness space; buys Endura Mass brand
The drug major said its wholly-owned subsidiary, Cipla Health, has signed definitive agreements for acquisition of Endura Mass from Medinnbelle Herbalcare.
-
ACC, Cipla, Bharti Airtel, Cipla, Angel One, Tata Elxsi, Jindal Steel and Power, Tata Steel stocks in focus
Indian equity markets are likely to open higher on Friday. SGX Nifty was up with gains signalling that Dalal Street is headed for a positive start, while global cues were mixed.
-
Stocks to Watch Today: Tata Elxsi, ACC, Cipla, Adani Group Stocks and Others
Stocks to watch today: Shares of firms like Tata Elxsi, ACC, Cipla, Adani Group Stocks, and others will be in focus in Friday's trade
-
Buy Cipla, target price Rs 1095: ICICI Direct
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 75727.57 Crore) operating in Pharmaceuticals sector.
-
Buy Cipla, target price Rs 1085: Prabhudas Lilladher
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 75457.28 Crore) operating in Pharmaceuticals sector.
-
India shares higher at close of trade; Nifty 50 up 0.89%
Investing.com – India equities were higher at the close on Thursday, as gains in the Metals, Consumer Durables and Real Estate sectors propelled shares higher. At the close in NSE, the...
-
Pace of ANDA approvals needs to quicken for top pharma players
Constant price erosion in the US markets means that volumes and new products are necessary to act as levers for growth
-
Cipla's Indore plant gets two USFDA observations
The US Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) at the drug major's Indore plant from 27 June 2022 to 1 July 2022.
-
USFDA issues two observations for Cipla's Indore plant
Following a Pre-Approval Inspection
-
Stocks in news: TCS, Vedanta, Tata Power, Cipla and more
Stocks in news: Kotak Mahindra Bank, TCS, Vedanta, Tata Power, Cipla and more
-
India shares lower at close of trade; Nifty 50 down 0.12%
Investing.com – India equities were lower at the close on Thursday, as losses in the Metals, Auto and Real Estate sectors propelled shares lower. At the close in NSE, the Nifty 50 fell...
-
Blue-Chip Stocks in Focus: RIL, Tata Steel, Bajaj Auto & More
By Malvika Gurung Investing.com -- Reliance Industries (NS:RELI): The telecom-to-retail conglomerate’s electric commercial vehicle maker Altigreen inaugurated its EV service centre in...
-
Stocks Under Focus on May 11: Cipla, SBI, Adani Ports, PNB, Vodafone Idea & More
By Malvika Gurung Investing.com -- State Bank of India (NS:BOI): The public lender’s board has approved raising up to $2 billion or Rs 15,430 crore in the ongoing fiscal from overseas...
-
Stocks Under Focus on May 10: HCL Tech, Asian Paints, Rainbow Children’s & More
By Malvika Gurung Investing.com -- HCL Tech: The IT giant’s subsidiary will acquire the Bengaluru-based aftermarket digital transformation company Quest Informatics, in an all-cash deal for...
-
Foreign Investors Slash & Add Stakes in These Nifty Stocks in Q4; Bearish Sectors
By Malvika Gurung Investing.com -- Foreign investors have continued their selling spree in the quarter ending March 2022, offloading Indian shares worth over Rs 1.1 lakh crore, while selling...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
